Phase I/II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) in Patients With Untreated Metastatic Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 12 Nov 2008
At a glance
- Drugs Folinic acid (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Nov 2008 Last checked against ClinicalTrials.gov.
- 12 Nov 2008 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.